BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17483710)

  • 1. Extracranial relapse of an anaplastic oligodendroglioma in an adolescent: case report and review of the literature.
    Bruggers C; White K; Zhou H; Chen Z
    J Pediatr Hematol Oncol; 2007 May; 29(5):319-22. PubMed ID: 17483710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaplastic oligodendroglioma and oligoastrocytoma.
    van den Bent MJ
    Neurol Clin; 2007 Nov; 25(4):1089-109, ix-x. PubMed ID: 17964027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in diagnosis and management of oligodendroglioma.
    Hussein MR; Baidas S
    Expert Rev Anticancer Ther; 2002 Oct; 2(5):520-8. PubMed ID: 12382520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligodendroglioma.
    Van den Bent MJ; Reni M; Gatta G; Vecht C
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):262-72. PubMed ID: 18272388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?
    Weller M; Berger H; Hartmann C; Schramm J; Westphal M; Simon M; Goldbrunner R; Krex D; Steinbach JP; Ostertag CB; Loeffler M; Pietsch T; von Deimling A;
    Clin Cancer Res; 2007 Dec; 13(23):6933-7. PubMed ID: 18056167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.
    van den Bent MJ; Looijenga LH; Langenberg K; Dinjens W; Graveland W; Uytdewilligen L; Sillevis Smitt PA; Jenkins RB; Kros JM
    Cancer; 2003 Mar; 97(5):1276-84. PubMed ID: 12599236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastomatous recurrence of oligodendroglioma remote from the original site: a case report.
    Kocaeli H; Yakut T; Bekar A; Taşkapilioğlu O; Tolunay S
    Surg Neurol; 2006 Dec; 66(6):627-30; discussion 630-1. PubMed ID: 17145331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extraneural metastases of anaplastic oligodendroglial tumors.
    Volavsek M; Lamovec J; Popović M
    Pathol Res Pract; 2009; 205(7):502-7. PubMed ID: 19410385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytologic diagnosis of a metastatic oligodendroglioma in a pleural effusion. A case report.
    Lee CC; Jiang JS; Chen ET; Yokoo H; Pan YH; Tsai MD
    Acta Cytol; 2006; 50(5):542-4. PubMed ID: 17017442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.
    Stege EM; Kros JM; de Bruin HG; Enting RH; van Heuvel I; Looijenga LH; van der Rijt CD; Smitt PA; van den Bent MJ
    Cancer; 2005 Feb; 103(4):802-9. PubMed ID: 15637687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours.
    Jenkinson MD; Smith TS; Joyce KA; Fildes D; Broome J; du Plessis DG; Haylock B; Husband DJ; Warnke PC; Walker C
    Neuroradiology; 2006 Oct; 48(10):703-13. PubMed ID: 16937145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of oligodendroglial tumours: current developments.
    van den Bent MJ
    Forum (Genova); 2000; 10(2):108-18. PubMed ID: 10875973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of treatment recommendations for anaplastic oligodendroglioma.
    Abrey LE; Louis DN; Paleologos N; Lassman AB; Raizer JJ; Mason W; Finlay J; MacDonald DR; DeAngelis LM; Cairncross JG;
    Neuro Oncol; 2007 Jul; 9(3):314-8. PubMed ID: 17435180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of oligodendroglioma.
    Smits M
    Br J Radiol; 2016; 89(1060):20150857. PubMed ID: 26849038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of oligodendroglioma: an update.
    Paleologos NA; Cairncross JG
    Neuro Oncol; 1999 Jan; 1(1):61-8. PubMed ID: 11550303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From the archives of the AFIP: Oligodendroglioma and its variants: radiologic-pathologic correlation.
    Koeller KK; Rushing EJ
    Radiographics; 2005; 25(6):1669-88. PubMed ID: 16284142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.
    Rodriguez FJ; Scheithauer BW; Jenkins R; Burger PC; Rudzinskiy P; Vlodavsky E; Schooley A; Landolfi J
    Am J Surg Pathol; 2007 Mar; 31(3):351-62. PubMed ID: 17325476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma.
    Chamberlain MC; Glantz MJ
    Neurosurgery; 2008 Oct; 63(4):720-6; author reply 726-7. PubMed ID: 18981882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual uterine recurrence of primary central nervous system lymphoma.
    Nichols GL; Jacobson CA; Ferman D; Lichtman SM
    Clin Adv Hematol Oncol; 2006 Sep; 4(9):697-8, discussion 699-700. PubMed ID: 17099627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.